Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 58 entries
Sorted by: Best Match Show Resources per page
Comparison of the Psychological Symptoms and Disease-Specific Quality of Life between Early- and Typical-Onset Parkinson's Disease Patients.

Parkinson's disease

Fereshtehnejad SM, Hadizadeh H, Farhadi F, Shahidi GA, Delbari A, Lökk J.
PMID: 25614849
Parkinsons Dis. 2014;2014:819260. doi: 10.1155/2014/819260. Epub 2014 Dec 29.

The impact of Parkinson's disease (PD) on psychological status and quality of life (QoL) may vary depending on age of disease onset. The aim of this study was to compare psychological symptoms and disease-specific QoL between early onset versus...

Cite
Fereshtehnejad SM, Hadizadeh H, Farhadi F, et al. Comparison of the Psychological Symptoms and Disease-Specific Quality of Life between Early- and Typical-Onset Parkinson's Disease Patients. Parkinsons Dis. 2014;2014:819260doi: 10.1155/2014/819260.
Fereshtehnejad, S. M., Hadizadeh, H., Farhadi, F., Shahidi, G. A., Delbari, A., & Lökk, J. (2014). Comparison of the Psychological Symptoms and Disease-Specific Quality of Life between Early- and Typical-Onset Parkinson's Disease Patients. Parkinson's disease, 2014819260. https://doi.org/10.1155/2014/819260
Fereshtehnejad, Seyed-Mohammad, et al. "Comparison of the Psychological Symptoms and Disease-Specific Quality of Life between Early- and Typical-Onset Parkinson's Disease Patients." Parkinson's disease vol. 2014 (2014): 819260. doi: https://doi.org/10.1155/2014/819260
Fereshtehnejad SM, Hadizadeh H, Farhadi F, Shahidi GA, Delbari A, Lökk J. Comparison of the Psychological Symptoms and Disease-Specific Quality of Life between Early- and Typical-Onset Parkinson's Disease Patients. Parkinsons Dis. 2014;2014:819260. doi: 10.1155/2014/819260. Epub 2014 Dec 29. PMID: 25614849; PMCID: PMC4295150.
Copy Download .nbib Format: NLM
Comorbidity profile in dementia with Lewy bodies versus Alzheimer's disease: a linkage study between the Swedish Dementia Registry and the Swedish National Patient Registry.

Alzheimer's research & therapy

Fereshtehnejad SM, Damangir S, Cermakova P, Aarsland D, Eriksdotter M, Religa D.
PMID: 25478027
Alzheimers Res Ther. 2014 Oct 06;6(5):65. doi: 10.1186/s13195-014-0065-2. eCollection 2014.

INTRODUCTION: Compared to Alzheimer's disease (AD), dementia with Lewy bodies (DLB) is usually associated with a more complex clinical picture and higher burden of care. Yet, few investigations have been performed on comorbidities and risk factors of DLB. Therefore,...

Cite
Fereshtehnejad SM, Damangir S, Cermakova P, et al. Comorbidity profile in dementia with Lewy bodies versus Alzheimer's disease: a linkage study between the Swedish Dementia Registry and the Swedish National Patient Registry. Alzheimers Res Ther. 2014;6(5):65doi: 10.1186/s13195-014-0065-2.
Fereshtehnejad, S. M., Damangir, S., Cermakova, P., Aarsland, D., Eriksdotter, M., & Religa, D. (2014). Comorbidity profile in dementia with Lewy bodies versus Alzheimer's disease: a linkage study between the Swedish Dementia Registry and the Swedish National Patient Registry. Alzheimer's research & therapy, 6(5), 65. https://doi.org/10.1186/s13195-014-0065-2
Fereshtehnejad, Seyed-Mohammad, et al. "Comorbidity profile in dementia with Lewy bodies versus Alzheimer's disease: a linkage study between the Swedish Dementia Registry and the Swedish National Patient Registry." Alzheimer's research & therapy vol. 6,5 (2014): 65. doi: https://doi.org/10.1186/s13195-014-0065-2
Fereshtehnejad SM, Damangir S, Cermakova P, Aarsland D, Eriksdotter M, Religa D. Comorbidity profile in dementia with Lewy bodies versus Alzheimer's disease: a linkage study between the Swedish Dementia Registry and the Swedish National Patient Registry. Alzheimers Res Ther. 2014 Oct 06;6(5):65. doi: 10.1186/s13195-014-0065-2. eCollection 2014. PMID: 25478027; PMCID: PMC4255539.
Copy Download .nbib Format: NLM
Complicated orolingual angioedema after recombinant tissue plasminogen activator treatment in stroke patients under angiotensin converting enzyme inhibitor: Report of two cases.

Iranian journal of neurology

Motamed MR, Nasiri F, Fereshtehnejad SM, Mehrpour M, Zamani B, Haghi-Ashtiani B, Rohani F.
PMID: 26885343
Iran J Neurol. 2015 Oct 07;14(4):225-7.

No abstract available.

Cite
Motamed MR, Nasiri F, Fereshtehnejad SM, et al. Complicated orolingual angioedema after recombinant tissue plasminogen activator treatment in stroke patients under angiotensin converting enzyme inhibitor: Report of two cases. Iran J Neurol. 2015;14(4):225-7
Motamed, M. R., Nasiri, F., Fereshtehnejad, S. M., Mehrpour, M., Zamani, B., Haghi-Ashtiani, B., & Rohani, F. (2015). Complicated orolingual angioedema after recombinant tissue plasminogen activator treatment in stroke patients under angiotensin converting enzyme inhibitor: Report of two cases. Iranian journal of neurology, 14(4), 225-7.
Motamed, Mohammad Reza, et al. "Complicated orolingual angioedema after recombinant tissue plasminogen activator treatment in stroke patients under angiotensin converting enzyme inhibitor: Report of two cases." Iranian journal of neurology vol. 14,4 (2015): 225-7.
Motamed MR, Nasiri F, Fereshtehnejad SM, Mehrpour M, Zamani B, Haghi-Ashtiani B, Rohani F. Complicated orolingual angioedema after recombinant tissue plasminogen activator treatment in stroke patients under angiotensin converting enzyme inhibitor: Report of two cases. Iran J Neurol. 2015 Oct 07;14(4):225-7. PMID: 26885343; PMCID: PMC4754603.
Copy Download .nbib Format: NLM
Anxiety and depression in patients with amputated limbs suffering from phantom pain: a comparative study with non-phantom chronic pain.

International journal of preventive medicine

Kazemi H, Ghassemi S, Fereshtehnejad SM, Amini A, Kolivand PH, Doroudi T.
PMID: 23543814
Int J Prev Med. 2013 Feb;4(2):218-25.

BACKGROUND: Phantom limb pain (PLP) is approximately a common condition after limb amputation, which potentially affects the quality of life. We aimed to evaluate anxiety and depression in patients with amputated limbs suffering from PLP and to compare these...

Cite
Kazemi H, Ghassemi S, Fereshtehnejad SM, et al. Anxiety and depression in patients with amputated limbs suffering from phantom pain: a comparative study with non-phantom chronic pain. Int J Prev Med. 2013;4(2):218-25
Kazemi, H., Ghassemi, S., Fereshtehnejad, S. M., Amini, A., Kolivand, P. H., & Doroudi, T. (2013). Anxiety and depression in patients with amputated limbs suffering from phantom pain: a comparative study with non-phantom chronic pain. International journal of preventive medicine, 4(2), 218-25.
Kazemi, Hadi, et al. "Anxiety and depression in patients with amputated limbs suffering from phantom pain: a comparative study with non-phantom chronic pain." International journal of preventive medicine vol. 4,2 (2013): 218-25.
Kazemi H, Ghassemi S, Fereshtehnejad SM, Amini A, Kolivand PH, Doroudi T. Anxiety and depression in patients with amputated limbs suffering from phantom pain: a comparative study with non-phantom chronic pain. Int J Prev Med. 2013 Feb;4(2):218-25. PMID: 23543814; PMCID: PMC3604856.
Copy Download .nbib Format: NLM
Serum uric acid level in acute stroke patients.

Medical journal of the Islamic Republic of Iran

Mehrpour M, Khuzan M, Najimi N, Motamed MR, Fereshtehnejad SM.
PMID: 23483825
Med J Islam Repub Iran. 2012 May;26(2):66-72.

BACKGROUND: The role of uric acid as a risk factor for vascular disease and acute stroke is controversial and there is little information about it. In this study, we determined serum uric acid levels in patients with acute stroke...

Cite
Mehrpour M, Khuzan M, Najimi N, et al. Serum uric acid level in acute stroke patients. Med J Islam Repub Iran. 2012;26(2):66-72
Mehrpour, M., Khuzan, M., Najimi, N., Motamed, M. R., & Fereshtehnejad, S. M. (2012). Serum uric acid level in acute stroke patients. Medical journal of the Islamic Republic of Iran, 26(2), 66-72.
Mehrpour, Masoud, et al. "Serum uric acid level in acute stroke patients." Medical journal of the Islamic Republic of Iran vol. 26,2 (2012): 66-72.
Mehrpour M, Khuzan M, Najimi N, Motamed MR, Fereshtehnejad SM. Serum uric acid level in acute stroke patients. Med J Islam Repub Iran. 2012 May;26(2):66-72. PMID: 23483825; PMCID: PMC3587902.
Copy Download .nbib Format: NLM
Adult-onset familial mediterranean Fever in northwestern iran; clinical feature and treatment outcome.

Middle East journal of digestive diseases

Nobakht H, Zamani F, Ajdarkosh H, Mohamadzadeh Z, Fereshtehnejad S, Nassaji M.
PMID: 25197532
Middle East J Dig Dis. 2011 Mar;3(1):50-5.

BACKGROUND Familial Mediterranean fever (FMF) is an autosomal recessive disorder characterized by sporadic, paroxysmal attacks of fever and serosal inflammation. Although the disease usually begins before the age of 20 years, we aimed to evaluate the demography, clinical features...

Cite
Nobakht H, Zamani F, Ajdarkosh H, et al. Adult-onset familial mediterranean Fever in northwestern iran; clinical feature and treatment outcome. Middle East J Dig Dis. 2011;3(1):50-5
Nobakht, H., Zamani, F., Ajdarkosh, H., Mohamadzadeh, Z., Fereshtehnejad, S., & Nassaji, M. (2011). Adult-onset familial mediterranean Fever in northwestern iran; clinical feature and treatment outcome. Middle East journal of digestive diseases, 3(1), 50-5.
Nobakht, H, et al. "Adult-onset familial mediterranean Fever in northwestern iran; clinical feature and treatment outcome." Middle East journal of digestive diseases vol. 3,1 (2011): 50-5.
Nobakht H, Zamani F, Ajdarkosh H, Mohamadzadeh Z, Fereshtehnejad S, Nassaji M. Adult-onset familial mediterranean Fever in northwestern iran; clinical feature and treatment outcome. Middle East J Dig Dis. 2011 Mar;3(1):50-5. PMID: 25197532; PMCID: PMC4154930.
Copy Download .nbib Format: NLM
Long Lag Between Drug-induced Parkinsonism and Idiopathic Parkinson's Disease in Idiopathic REM Sleep Behavior Disorder.

Movement disorders clinical practice

Fereshtehnejad SM, Dawson BK, Pelletier A, Montplaisir JY, Postuma RB.
PMID: 30746401
Mov Disord Clin Pract. 2018 Jan 10;5(2):203-205. doi: 10.1002/mdc3.12576. eCollection 2018.

No abstract available.

Cite
Fereshtehnejad SM, Dawson BK, Pelletier A, et al. Long Lag Between Drug-induced Parkinsonism and Idiopathic Parkinson's Disease in Idiopathic REM Sleep Behavior Disorder. Mov Disord Clin Pract. 2018;5(2):203-205doi: 10.1002/mdc3.12576.
Fereshtehnejad, S. M., Dawson, B. K., Pelletier, A., Montplaisir, J. Y., & Postuma, R. B. (2018). Long Lag Between Drug-induced Parkinsonism and Idiopathic Parkinson's Disease in Idiopathic REM Sleep Behavior Disorder. Movement disorders clinical practice, 5(2), 203-205. https://doi.org/10.1002/mdc3.12576
Fereshtehnejad, Seyed-Mohammad, et al. "Long Lag Between Drug-induced Parkinsonism and Idiopathic Parkinson's Disease in Idiopathic REM Sleep Behavior Disorder." Movement disorders clinical practice vol. 5,2 (2018): 203-205. doi: https://doi.org/10.1002/mdc3.12576
Fereshtehnejad SM, Dawson BK, Pelletier A, Montplaisir JY, Postuma RB. Long Lag Between Drug-induced Parkinsonism and Idiopathic Parkinson's Disease in Idiopathic REM Sleep Behavior Disorder. Mov Disord Clin Pract. 2018 Jan 10;5(2):203-205. doi: 10.1002/mdc3.12576. eCollection 2018. PMID: 30746401; PMCID: PMC6336185.
Copy Download .nbib Format: NLM
Non-alcoholic fatty liver disease and correlation of serum alanin aminotransferase level with histopathologic findings.

Hepatitis monthly

Khosravi S, Alavian SM, Zare A, Daryani NE, Fereshtehnejad SM, Daryani NE, Keramati MR, Abdollahzade S, Taba Taba Vakili S.
PMID: 22087177
Hepat Mon. 2011 Jun;11(6):452-8.

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) has been recognized as the most common cause of chronic liver disease worldwide. It occurs in patients who do not consume alcohol in large amounts. Alanine aminotranferase (ALT) and aspartate aminotransferase (AST) are...

Cite
Khosravi S, Alavian SM, Zare A, et al. Non-alcoholic fatty liver disease and correlation of serum alanin aminotransferase level with histopathologic findings. Hepat Mon. 2011;11(6):452-8
Khosravi, S., Alavian, S. M., Zare, A., Daryani, N. E., Fereshtehnejad, S. M., Daryani, N. E., Keramati, M. R., Abdollahzade, S., & Taba Taba Vakili, S. (2011). Non-alcoholic fatty liver disease and correlation of serum alanin aminotransferase level with histopathologic findings. Hepatitis monthly, 11(6), 452-8.
Khosravi, Somaye, et al. "Non-alcoholic fatty liver disease and correlation of serum alanin aminotransferase level with histopathologic findings." Hepatitis monthly vol. 11,6 (2011): 452-8.
Khosravi S, Alavian SM, Zare A, Daryani NE, Fereshtehnejad SM, Daryani NE, Keramati MR, Abdollahzade S, Taba Taba Vakili S. Non-alcoholic fatty liver disease and correlation of serum alanin aminotransferase level with histopathologic findings. Hepat Mon. 2011 Jun;11(6):452-8. PMID: 22087177; PMCID: PMC3212791.
Copy Download .nbib Format: NLM
Prodromal Parkinson disease subtypes - key to understanding heterogeneity.

Nature reviews. Neurology

Berg D, Borghammer P, Fereshtehnejad SM, Heinzel S, Horsager J, Schaeffer E, Postuma RB.
PMID: 33879872
Nat Rev Neurol. 2021 Jun;17(6):349-361. doi: 10.1038/s41582-021-00486-9. Epub 2021 Apr 20.

In Parkinson disease (PD), pathological processes and neurodegeneration begin long before the cardinal motor symptoms develop and enable clinical diagnosis. In this prodromal phase, risk and prodromal markers can be used to identify individuals who are likely to develop...

Cite
Berg D, Borghammer P, Fereshtehnejad SM, et al. Prodromal Parkinson disease subtypes - key to understanding heterogeneity. Nat Rev Neurol. 2021;17(6):349-361doi: 10.1038/s41582-021-00486-9.
Berg, D., Borghammer, P., Fereshtehnejad, S. M., Heinzel, S., Horsager, J., Schaeffer, E., & Postuma, R. B. (2021). Prodromal Parkinson disease subtypes - key to understanding heterogeneity. Nature reviews. Neurology, 17(6), 349-361. https://doi.org/10.1038/s41582-021-00486-9
Berg, Daniela, et al. "Prodromal Parkinson disease subtypes - key to understanding heterogeneity." Nature reviews. Neurology vol. 17,6 (2021): 349-361. doi: https://doi.org/10.1038/s41582-021-00486-9
Berg D, Borghammer P, Fereshtehnejad SM, Heinzel S, Horsager J, Schaeffer E, Postuma RB. Prodromal Parkinson disease subtypes - key to understanding heterogeneity. Nat Rev Neurol. 2021 Jun;17(6):349-361. doi: 10.1038/s41582-021-00486-9. Epub 2021 Apr 20. PMID: 33879872.
Copy Download .nbib Format: NLM
Validity and Reliability of the Persian Version of Parkinson's Disease Sleep Scale-2.

Parkinson's disease

Joghataei MT, Fereshtehnejad SM, Mehdizadeh M, Goudarzi S, Habibi SAH, Meimandi M, Dehmiyani A, Taghizadeh G.
PMID: 34966538
Parkinsons Dis. 2021 Dec 20;2021:2015123. doi: 10.1155/2021/2015123. eCollection 2021.

OBJECTIVE: Sleep problems are nonmotor symptoms in Parkinson's disease that should be carefully evaluated for better management and treatment. Parkinson's Disease Sleep Scale (PDSS-2) is one of the most reliable tools for measuring sleep difficulties in people with Parkinson's...

Cite
Joghataei MT, Fereshtehnejad SM, Mehdizadeh M, et al. Validity and Reliability of the Persian Version of Parkinson's Disease Sleep Scale-2. Parkinsons Dis. 2021;2021:2015123doi: 10.1155/2021/2015123.
Joghataei, M. T., Fereshtehnejad, S. M., Mehdizadeh, M., Goudarzi, S., Habibi, S. A. H., Meimandi, M., Dehmiyani, A., & Taghizadeh, G. (2021). Validity and Reliability of the Persian Version of Parkinson's Disease Sleep Scale-2. Parkinson's disease, 20212015123. https://doi.org/10.1155/2021/2015123
Joghataei, Mohammad Taghi, et al. "Validity and Reliability of the Persian Version of Parkinson's Disease Sleep Scale-2." Parkinson's disease vol. 2021 (2021): 2015123. doi: https://doi.org/10.1155/2021/2015123
Joghataei MT, Fereshtehnejad SM, Mehdizadeh M, Goudarzi S, Habibi SAH, Meimandi M, Dehmiyani A, Taghizadeh G. Validity and Reliability of the Persian Version of Parkinson's Disease Sleep Scale-2. Parkinsons Dis. 2021 Dec 20;2021:2015123. doi: 10.1155/2021/2015123. eCollection 2021. PMID: 34966538; PMCID: PMC8712149.
Copy Download .nbib Format: NLM
Validity and Reliability of Short-Form McGill Pain Questionnaire-2 (SF-MPQ-2) in Iranian People with Parkinson's Disease.

Parkinson's disease

Mehdizadeh M, Fereshtehnejad SM, Goudarzi S, Moshtagh A, Dehghanian Nasrabadi F, Habibi SAH, Taghizadeh G.
PMID: 32908666
Parkinsons Dis. 2020 Aug 18;2020:2793945. doi: 10.1155/2020/2793945. eCollection 2020.

PURPOSE: Pain is one of the nonmotor symptoms of Parkinson's disease (PD) that, in order to be better managed, requires to be evaluated. Evaluations are done using pain assessment scales such as the Short-Form McGill Pain Questionnaire-2 (SF-MPQ-2). The...

Cite
Mehdizadeh M, Fereshtehnejad SM, Goudarzi S, et al. Validity and Reliability of Short-Form McGill Pain Questionnaire-2 (SF-MPQ-2) in Iranian People with Parkinson's Disease. Parkinsons Dis. 2020;2020:2793945doi: 10.1155/2020/2793945.
Mehdizadeh, M., Fereshtehnejad, S. M., Goudarzi, S., Moshtagh, A., Dehghanian Nasrabadi, F., Habibi, S. A. H., & Taghizadeh, G. (2020). Validity and Reliability of Short-Form McGill Pain Questionnaire-2 (SF-MPQ-2) in Iranian People with Parkinson's Disease. Parkinson's disease, 20202793945. https://doi.org/10.1155/2020/2793945
Mehdizadeh, Maryam, et al. "Validity and Reliability of Short-Form McGill Pain Questionnaire-2 (SF-MPQ-2) in Iranian People with Parkinson's Disease." Parkinson's disease vol. 2020 (2020): 2793945. doi: https://doi.org/10.1155/2020/2793945
Mehdizadeh M, Fereshtehnejad SM, Goudarzi S, Moshtagh A, Dehghanian Nasrabadi F, Habibi SAH, Taghizadeh G. Validity and Reliability of Short-Form McGill Pain Questionnaire-2 (SF-MPQ-2) in Iranian People with Parkinson's Disease. Parkinsons Dis. 2020 Aug 18;2020:2793945. doi: 10.1155/2020/2793945. eCollection 2020. PMID: 32908666; PMCID: PMC7450331.
Copy Download .nbib Format: NLM
Insomnia symptom subtypes and manifestations of prodromal neurodegeneration: a population-based study in the CLSA.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine

Yao CW, Pelletier A, Fereshtehnejad SM, Cross N, Dang-Vu T, Postuma RB.
PMID: 34314348
J Clin Sleep Med. 2021 Jul 27; doi: 10.5664/jcsm.9562. Epub 2021 Jul 27.

STUDY OBJECTIVES: To identify the association between insomnia symptoms and signs of prodromal neurodegeneration, including an analysis of potential differences between sleep-onset and sleep-maintenance insomnia.METHODS: We included those aged 45-85 years, living in one of 10 Canadian provinces in...

Cite
Yao CW, Pelletier A, Fereshtehnejad SM, et al. Insomnia symptom subtypes and manifestations of prodromal neurodegeneration: a population-based study in the CLSA. J Clin Sleep Med. 2021;doi: 10.5664/jcsm.9562.
Yao, C. W., Pelletier, A., Fereshtehnejad, S. M., Cross, N., Dang-Vu, T., & Postuma, R. B. (2021). Insomnia symptom subtypes and manifestations of prodromal neurodegeneration: a population-based study in the CLSA. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, . https://doi.org/10.5664/jcsm.9562
Yao, Chun W, et al. "Insomnia symptom subtypes and manifestations of prodromal neurodegeneration: a population-based study in the CLSA." Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine vol. (2021). doi: https://doi.org/10.5664/jcsm.9562
Yao CW, Pelletier A, Fereshtehnejad SM, Cross N, Dang-Vu T, Postuma RB. Insomnia symptom subtypes and manifestations of prodromal neurodegeneration: a population-based study in the CLSA. J Clin Sleep Med. 2021 Jul 27; doi: 10.5664/jcsm.9562. Epub 2021 Jul 27. PMID: 34314348.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 58 entries